Randy Levinson, Deputy Editor of the Cell Press journal Cell Metabolism, will be exploring the latest research advances at the upcoming Keystone Symposia “Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches“ meeting, which will be held February 19-23 in Victoria, BC, Canada. This joint meeting with “Stromal Cells in Immunity and Disease” takes a unique and integrative perspective on how the body repairs damaged tissues, both in the context of healthy repair and aberrant disease processes.
Levinson will be hearing about a broad range of disease topics. Fibrosis affects nearly all tissues and organ systems and is a major pathogenic feature of many chronic inflammatory diseases including interstitial lung disease, nonalcoholic steatohepatitis (NASH), glomerulonephritis, heart disease, Crohn’s disease, and systemic sclerosis. Fibrotic tissue remodeling also influences cancer metastasis and cancer therapy. Recent advances have provided a deeper understanding of the pathogenesis of fibrosis and have revealed exciting new drug targets that are at various stages of clinical development.
The conference brings together researchers from a broad range of interests including epithelial biology, vascular biology, cancer, stem and tissue progenitor cell biology, tissue repair and regeneration, as well as those with disease-specific interests, to collectively address these issues and generate novel ideas and solutions.
Follow up-to-the-minute coverage of the Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches Meeting on Twitter:
Here we connect with Levinson about what he looks forward to at the meeting, and his goals as Deputy Editor of Cell Metabolism.
Why are you attending this conference? What do you hope to get out of it?
Dr. Randy Levinson: I am attending the Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches Conference to learn more about this topic from a metabolism point of view, recruit relevant papers from attendees, and to better interact with the community to help them be more aware of our interest in the topic.
What new directions and insights are you expecting to discover? What new frontiers are being addressed at this meeting?
Dr. Randy Levinson: I am hoping to learn more about how changes in cellular and tissue metabolism drive fibrosis pathophysiology as I see this is a potentially important emergent concept in the field and its one that my colleagues and I at Cell Metabolism want to foster.
What’s your top tip for a scientist looking to publish in your journal?
Dr. Randy Levinson:
Don’t be shy about directly reaching out to me or one of my colleagues to ask about our interest in your new study.
And doing so before the writing stage, and while there is time to do more experiments, is actually best as then any advice we might have can still be incorporated into the manuscript.
What’s the best way for attendees to get in touch with you at the meeting?
Dr. Randy Levinson:
Email me at: firstname.lastname@example.org
CAREER INSIGHTS- What advice would you offer scientists who are thinking about editorial careers?
Dr. Randy Levinson: Read widely and expose yourself to key concepts in a variety of different fields to help expand your scientific scope.
The editorial field is a great one for individuals who are naturally curious and enjoy learning new concepts and helping to foster the direction of science.
About the Author
Randy Levinson, Deputy Editor of the journal Cell Metabolism of Cell Press
As an undergraduate student at Caltech, Levinson studied Alphavirus evolution and the regulation of their replication in the lab of Dr. James Strauss. He earned his Ph.D from the University of California, San Francisco, where he studied nuclear hormone receptor signaling with Dr. Keith Yamamoto. After graduation, he carried on postdoctoral work with Dr. Eseng Lai at Memorial Sloan-Kettering Cancer Center investigating the role of renal stroma in embryonic kidney development. He continued these studies during a second postdoc at Columbia University with Dr. Cathy Mendelsohn before starting at Nature Medicine in 2005 as a manuscript editor. In 2018 he joined the team at Cell Metabolism as a Senior Scientific Editor, where he is now Deputy Editor.